why choose us

First received: November 15, 2022

Clinical Trial: A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Study Status: Completed

Recruit Status: RECRUITING

Condition: Geographic Atrophy

Study Type: INTERVENTIONAL


Official Title: A Phase IIa, Multicenter, Open-Label, Single-Arm Study To Optimize Subretinal Surgical Delivery And To Evaluate Safety And Activity Of Opregen In Patients With Geographic Atrophy Secondary to Age-Rela

Brief Summary: This study will evaluate the success and safety of subretinal surgical delivery as well as the preliminary activity of OpRegen in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).All endpoints are assessed for the study eye unless otherwise indicated.

Read more